Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tofacitinib citrate - CAGE Bio

Next Previous
Drug Profile

Tofacitinib citrate - CAGE Bio

Alternative Names: 1% Tofacitinib - CAGE Bio; CGB-500; Tofacitinib citrate ointment

Latest Information Update: 20 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CAGE Bio
  • Class 2 ring heterocyclic compounds; Amides; Anti-inflammatories; Antiasthmatics; Antineoplastics; Antipsoriatics; Antirheumatics; Eye disorder therapies; Irritable bowel syndrome therapies; Nitriles; Piperidines; Pyrimidines; Pyrroles; Skin disorder therapies; Small molecules
  • Mechanism of Action Janus kinase 1 inhibitors; Janus kinase 2 inhibitors; Janus kinase 3 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis

Most Recent Events

  • 30 Sep 2025 CAGE Bio completes phase-II clinical trials in Atopic dermatitis (In adolescents, In adults, In the elderly) in USA (Topical) (NCT06923228)
  • 04 Sep 2025 Efficacy and adverse events data from a phase-II clinical trials in Atopic dermatitis released by CAGE Bio
  • 21 Apr 2025 CAGE Bio initiates phase-II clinical trials in Atopic dermatitis (In adolescents, In adults, In the elderly) in USA (Topical) (NCT06923228)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top